Genomics, Artificial Intelligence, Biology, Pharmaceutical, Cancer.
alter promoter selection and gene expression profiles in cancer. Cognit’s LGM utilizes this data to predict the consequences of targeting specific Mediator subunits, potentially uncovering novel strategies to disrupt aberrant transcriptional programs in cancer cells. Dissecting Chromatin